EKF signs up Peruvian distributor; wins €1 m contract

Wednesday, Sep 29 2010 by
1
EKF signs up Peruvian distributor wins 1 m contract

EKF Diagnostics (LON:EKF) , the Point of Care in-vitro diagnostics company, announced that it has signed a distribution agreement with Diagnostica Peruana SAC in Peru. Under the agreement, Diagnostica Peruana will distrubute and provide customer support for EKF's Hemo-Control product. Hemo-Control is a Point of Care blood haemoglobin and hematocrit test instrument designed for use in doctors' offices. The Hemo-Control system is used to screen for illnesses such as diabetes and anaemia.

EKF also received a Hemo-Control order worth over €1 million from the Peruvian Ministry of Health (MINSA). The contract is for the purchase of 3,000 Hemo-Control devices along with an initial two month supply of consumable cuvettes (transparent tubes which hold blood test samples). The Company is currently tendering for the ongoing supply of cuvettes to MINSA, and because the Hemo-Control device requires EKF's proprietary cuvettes the company is confident that this effort will be successful. Recurring sales of consumables such as the cuvettes used in Hemo-Control tests are a key component of EKF's business model.

In other news, EKF’s board announced that CEO Julian Baines and Exec Chairman David Evans have been granted options on EKF Diagnostics Shares which amount to 6% each of the companies issued share capital.


About the Author's Company

LCF Research Profile Image Promotional
LCF Research

LCF Research is an independent, investor led investment research resource for private investors and fund managers.  We do not seek to replicate the full coverage model of stockbrokers and independent research houses.  Instead we aim to ask the key due diligence questions that should be posed prior to an investment… ...read more or visit website »


Disclaimer:  

This note was prepared by LCF Research Limited using information provided by the subject company’s management or publically available news sources. No representations are made nor warranties given (express or implied) in relation to accuracy and completeness. This document is not an invitation to invest in the subject company and does not purport to contain all the necessary information that a prospective investor might require. LCF Research Limited recommends prospective investors to conduct their own thorough independent analysis of the subject company and the information contained in this note or referred to above.


Do you like this Post?
Yes
No
1 thumb up
0 thumbs down
Share this post with friends



EKF Diagnostics Holdings Plc is focused on the In-Vitro Diagnostic device (IVD) market place. The Company is engaged in the designing, development, manufacture and selling of diagnostic instruments, reagents and certain ancillary products. This activity takes place across various geographical locations which include the United States America, Germany, Poland, Russia, United Kingdom and Ireland. The Company’s segments include the manufacture and sale of medical diagnostic equipment. Other services include the servicing and distribution of third party company products under separate distribution agreements. In March 2014, EKF Diagnostics Holdings PLC acquired Separation Technology Inc. The subsidiaries include: EKF Diagnostics Limited; Quotient Diagnostics Limited; EKF-diagnostic GmbH Germany; Senslab GmbH 2; EKF Diagnostyka Sp.z.o.o. ;EKF Diagnostika ; EKF Diagnostics Inc ; Stanbio Laboratory LP ; Stanbio Life Sciences LP ; EKF Diagnostics Limited, and 360 Genomics Limited. more »

Share Price (AIM)
21.5p
Change
-0.3  -1.2%
P/E (fwd)
n/a
Mkt Cap (£m)
90.7



  Is EKF Diagnostics Holdings fundamentally strong or weak? Find out More »


What's your view on this article? Log In to Comment Now

You can track all @StockoChat comments via Twitter


About LCF Research

LCF Research

LCF Research is an independent, investor led investment research resource for private investors and fund managers.



Stock Picking Tutorial Centre

Most Popular Now
Portfolio review  winners losers and spinoffs
Portfolio review - winners, losers and spinoffs
Plethora Solutions Holdings Tue 2:43pm


Is Apple Still Undervalued
Is Apple Still Undervalued?
Apple Inc Mon 9:43pm

Plus 500 Does it add up
Plus 500: Does it add up?
Plus500 Fri 2:24pm

My portfolio review for Q1 2015
My portfolio review for Q1 2015
Vodafone Fri 9:53am



Stock Picking Simplified

Stockopedia takes your stock picking to the next level with cutting edge Stock Reports & Screening tools.


Get started
or Take a Tour to find out more.